SANTA CLARA, Calif., Jan. 30 /PRNewswire/ -- Applied Imaging Corp.
(Nasdaq: AICX) announced today that Mr. Carl Hull has been appointed Chief
Executive Officer and Director of the Company. Mr. Hull assumes the CEO role
from Dr. Jack Goldstein, who has been CEO since 1997 and who will continue to
remain active in the Company as Chairman of the Board of Directors. Mr.
Hull's transition to CEO at this time is part of Applied Imaging's established
management succession plan.
Mr. Hull joined the Company in 1997 as Vice-President of Marketing and was
promoted to President and COO in September 1999. Prior to joining Applied
Imaging in 1997, Mr. Hull was the Vice President of Marketing and Business
Development for Ventana Medical Systems, a manufacturer of automated pathology
testing systems. Prior to that, Mr. Hull held a number of general management
and marketing management positions with Abbott Laboratories in its diagnostics
and international operations. Mr. Hull holds a BA from The Johns Hopkins
University and an MBA from the University of Chicago.
"I am very pleased to be able to effect this management transition at this
time," said Jack Goldstein, Ph.D., Chairman of Applied Imaging. "Carl has
done a great job in working with me to develop and execute our new strategy
while building an outstanding management team. He brings a depth of knowledge
and experience in the medical diagnostics business that will be invaluable in
the execution of our strategy to position the company in the cancer pathology
market with our new MDS(TM) system. I am looking forward to working with Carl
to continue the long term growth of the Company."
The Company also announced the promotion of Mr. Daniel Bowman to the
position of Vice President -- Worldwide Sales and Marketing reporting to Mr.
Hull. In announcing the promotion, Hull noted that, "This well-deserved
promotion recognizes Dan's outstanding accomplishments in significantly
growing the company's business in the North American market. It also allows
us to develop consistent sales and marketing programs on a worldwide basis,
reflecting the increasingly global nature of our genomics-based business."
About Applied Imaging
Applied Imaging Corp., based in Santa Clara, California, is the leading
supplier of automated imaging systems utilized in genetics and pathology
laboratories for the analysis of chromosomes in cancer and prenatal disorders.
The Company is expanding its efforts in scanning and imaging applications in
the cancer pathology field. Applied Imaging has installed over 2000 systems
in 1000 laboratories in more than 35 countries.
About the MDS(TM) System
The MDS(TM) System is an advanced scanning microscopy system that uses
brightfield techniques to detect targeted cancer cells in concentrations as
low as one cell among one million other cells. Once detected, the MDS(TM)
utilizes proprietary fluorescence analysis software for the analysis of
multiple genetic markers within individual cells or in tissue sections taken
from primary tumors. The ability to detect and analyze multiple genetic
markers simultaneously allows researchers to develop panels of genetic tests
that may be used to select treatments and monitor individual patient responses
to therapy.
For additional information on Applied Imaging via fax, please dial
1-800-PRO-INFO, (732-544-2850 outside of the U.S.), code AICX, or visit the
company's web site at http://www.aicorp.com .
SOURCE Applied Imaging Corp.
 back to top
Related links:
http://www.aicorp.com
CONTACT:
Barry Hotchkies, CFO of Applied Imaging
Corp., 408-562-0250, or General, Pam Roberts, or Investor
Contact, James Hoyne, both of The Financial Relations Board,
415-986-1591
|
